News
Opexa Announces Top-Line Results from Phase IIb Clinical Trial of Tovaxin(R) for the Treatment of Multiple Sclerosis
Top-Line Data from Opexa's Phase IIb Tovaxin(R) Study to be Presented at World Congress on Treatment and Research in Multiple Sclerosis
Company Profile
Company History
Our Approach to Stem Cells
Error
You have reached this page in error, please check the url you have typed and try again.
